CK2 phosphorylation of Bdp1 executes cell cycle-specific RNA polymerase III transcription repression.
RNA polymerase III (pol III) transcription from the human U6 snRNA promoter can be reconstituted with the recombinant factors SNAPc and Brf2-TFIIIB combined with purified pol III. In this system, CK2 treatment of the pol III complex is required for transcription, whereas treatment of Brf2-TFIIIB is inhibitory. Here we show that CK2 inhibits Brf2-TFIIIB by specifically phosphorylating its Bdp1 component. Bdp1 is phosphorylated by CK2 during mitosis, and this is accompanied by Bdp1 dissociation from the U6 promoter and from chromatin in general and by transcription repression. Remarkably, whereas inhibition of CK2 in mitotic extracts restores pol III transcription, inhibition of CK2 in active S phase extracts debilitates transcription. Thus, CK2 is directed to phosphorylate different targets within the basal pol III transcription machinery at different times during the cell cycle, with opposite transcriptional effects.
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
Ping
P
Hu
Kalpana
K
Samudre
Si
S
Wu
Yuling
Y
Sun
Nouria
N
Hernandez
D047390:Casein Kinase II; D002453:Cell Cycle / Q000502:physiology*; D002843:Chromatin / Q000502:physiology; D017124:Conserved Sequence; D005786:Gene Expression Regulation / Q000502:physiology; D006801:Humans; D008938:Mitosis / Q000502:physiology; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D010766:Phosphorylation; D011401:Promoter Regions, Genetic; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism*; D017434:Protein Structure, Tertiary; D012320:RNA Polymerase III / Q000378:metabolism*; D035361:Transcription Factor TFIIIB; D014158:Transcription, Genetic
C427472:BDP1 protein, human; D002843:Chromatin; D009687:Nuclear Proteins; D035361:Transcription Factor TFIIIB; D047390:Casein Kinase II; D017346:Protein Serine-Threonine Kinases; D012320:RNA Polymerase III